✦ LIBER ✦

Maximal androgen blockade for patients with metastatic prostate cancer: outcome of a controlled trial of bicalutamide versus flutamide, each in combination with luteinizing hormone-releasing hormone analogue therapy

✍ Scribed by Paul Schellhammer; Roohollah Sharifi; Norman Block; Mark Soloway; Peter Venner; A.Lynn Patterson; Michael Sarosdy; Nicholas Vogelzang; Julie Jones; Geert Kolvenbag

Book ID: 119486743
Publisher: Elsevier Science
Year: 1996
Tongue: English
Weight: 840 KB
Volume: 47
Category: Article
ISSN: 0090-4295
DOI: 10.1016/s0090-4295(96)80010-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A controlled trial of bicalutamide versu

A controlled trial of bicalutamide versus flutamide, each in combination with luteinizing hormone-releasing hormone analogue therapy, in patients with advanced prostate cancer

✍ Paul Schellhammer; A. Lynn Patterson; Roohollah Sharifi; Michael Sarosdy; Norman 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 936 KB

A controlled trial of bicalutamide versu

A controlled trial of bicalutamide versus flutamide, each in combination with luteinizing hormone-releasing hormone analogue therapy, in patients with advanced prostate cancer

✍ E. David Crawford 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 141 KB

A controlled trial of bicalutamide versu

A controlled trial of bicalutamide versus flutamide, each in combination with luteinizing hormone-releasing hormone analogue therapy, in patients with advanced prostate cancer

✍ M. Zerbib; C. Payan 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 237 KB

The Cost-Effectiveness of Combined Andro

The Cost-Effectiveness of Combined Androgen Blockade With Bicalutamide and Luteinizing Hormone Releasing Hormone Agonist in Men With Metastatic Prostate Cancer

✍ Wei, J.T. 📂 Article 📅 2006 🏛 Elsevier Science ⚖ 66 KB

THE COST-EFFECTIVENESS OF COMBINED ANDRO

THE COST-EFFECTIVENESS OF COMBINED ANDROGEN BLOCKADE WITH BICALUTAMIDE AND LUTEINIZING HORMONE RELEASING HORMONE AGONIST IN MEN WITH METASTATIC PROSTATE CANCER

✍ PENSON, DAVID F.; RAMSEY, SCOTT; VEENSTRA, DAVID; CLARKE, LAUREN; GANDHI, SANJAY 📂 Article 📅 2005 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 370 KB

456 A randomized double-blind trial in 8

456 A randomized double-blind trial in 813 previously untreated metastatic prostate cancer (CaP) patients (PTS) comparing a new antiandrogen casodex® (bicalutamide) with eulexin (flutamide) in combination with luteinizing hormone releasing hormone analogue (LHRH-a) therapy

✍ N.J. Vogelzang; P.F. Schellhammer; R. Sharifi; N.L. Block; M.S. Soloway; P.M. Ve 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 137 KB